Quadrature Capital’s Ventyx Biosciences VTYX Stock Holding History

Quadrature Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,501	Closed	-$284K	–	1908
2025 Q4	$284K	Buy	+31,501	New	+$235K	﹤0.01%	868
2025 Q2	–	Sell	-21,148	Closed	-$24.5K	–	1550
2025 Q1	$24.5K	Buy	+21,148	New	+$36.3K	﹤0.01%	1024

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quadrature Capital's VTYX Position: Q1 2026 in Review

Quadrature Capital sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 31,501 shares — an estimated $284K sold.

Quadrature Capital first reported a position in VTYX in Q1 2025 and held it in 2 quarters. The position peaked at $284K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Quadrature Capital reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Quadrature Capital sold 31,501 Ventyx Biosciences shares in Q1 2026, an estimated $284K.
Quadrature Capital first reported a position in Ventyx Biosciences in Q1 2025 and held it in 2 quarters.
Quadrature Capital's Ventyx Biosciences position peaked at $284K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.